Gain Therapeutics, Inc. (GANX) Earning

$2.51

south_east
-$0.1 (-3.83%)
Day's range
$2.41
Day's range
$2.6

Gain Therapeutics, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2025 2 -$0.18 -$0.17 -$0.18
Q2 2025 1 -$0.17 -$0.17 -$0.17
Q3 2025 1 -$0.15 -$0.15 -$0.15
Q4 2025 1 -$0.16 -$0.16 -$0.16

Gain Therapeutics, Inc. Earnings Date And Information

Gain Therapeutics, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.17 earnings per share for the quarter, topping analysts' consensus estimates of $-0.23 by $0.06. The company had revenue of 0 for the quarter and had revenue of 55,180 for the year. Gain Therapeutics, Inc. has generated $-2 earnings per share over the last year ($-1.71 diluted earnings per share) and currently has a price-to-earnings ratio of -3.12. Gain Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 24th, 2025 based on prior year's report dates.

Gain Therapeutics, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/14/2024 Q3 2024 -$0.23 -$0.17 0.06 $10,000 $0
08/08/2024 Q2 2024 -$0.31 -$0.42 -0.11 $400,000 $0
05/14/2024 Q1 2024 -$0.30 -$0.22 0.08 N/A $0
03/26/2024 Q4 2023 -$0.32 -$0.29 0.03 N/A $64,800
11/14/2023 Q3 2023 -$0.47 -$0.37 0.1 $337,500 $0
08/10/2023 Q2 2023 -$0.33 -$0.62 -0.29 $1.01 M $0
05/12/2023 Q1 2023 -$0.40 -$0.43 -0.03 N/A $55,180
03/23/2023 Q4 2022 -$0.37 -$0.39 -0.02 N/A $140,108
11/10/2022 Q3 2022 -$0.46 -$0.38 0.08 $51,500 $0
08/08/2022 Q2 2022 -$0.35 -$0.43 -0.08 $31,667 $95,102
05/16/2022 Q1 2022 -$0.34 -$0.28 0.06 N/A $45,006
03/25/2022 Q4 2021 N/A -$0.32 N/A N/A $36,341
11/12/2021 Q3 2021 -$0.34 -$0.39 -0.05 $20,000 $27,345
08/12/2021 Q2 2021 N/A -$0.30 N/A N/A $89,173
05/10/2021 Q1 2021 -$0.21 -$0.50 -0.29 N/A $5,269
12/31/2020 Q4 2020 N/A -$0.15 N/A N/A $9,139
09/29/2020 Q3 2020 N/A -$0.30 N/A N/A $6,696
06/29/2020 Q2 2020 N/A -$0.20 N/A N/A $6,373
03/30/2020 Q1 2020 N/A -$0.22 N/A N/A $6,673
12/30/2019 Q4 2019 N/A -$0.32 N/A N/A $0

Gain Therapeutics, Inc. Earnings: FAQ's

Gain Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 24th, 2025 based offlast year's report dates.

In the previous quarter, Gain Therapeutics, Inc. (:GANX) reported $-0.17 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.23 by $0.06.

The conference call for Gain Therapeutics, Inc.'s latest earnings report can be listened to online.

The conference call transcript for Gain Therapeutics, Inc.'s latest earnings report can be read online.

Gain Therapeutics, Inc. (:GANX) has a recorded annual revenue of $55,180.

Gain Therapeutics, Inc. (:GANX) has a recorded net income of $-22,267,520.Gain Therapeutics, Inc. has generated $-1.71 earnings per share over the last four quarters.

Gain Therapeutics, Inc. (:GANX) has a price-to-earnings ratio of -3.12 and price/earnings-to-growth ratio is -0.23.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED